<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Savings or convenience? Why not both! Buy Diovan with us!</title>
	<atom:link href="http://www.orderdiovan.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.orderdiovan.com</link>
	<description></description>
	<pubdate>Mon, 12 Jan 2009 21:06:04 +0000</pubdate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
	<language></language>
			<item>
		<title>Chain Drug Review -  Novartis&#8217; Diovan O.K.&#8217;d for a new use</title>
		<link>http://www.orderdiovan.com/chain-drug-review-novartis-diovan-okd-for-a-new-use.html</link>
		<comments>http://www.orderdiovan.com/chain-drug-review-novartis-diovan-okd-for-a-new-use.html#comments</comments>
		<pubdate>Mon, 12 Jan 2009 21:06:04 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/chain-drug-review-novartis-diovan-okd-for-a-new-use.html</guid>
		<description><![CDATA[  EAST HANOVER, N.J. &#8212; The Food and Drug Administration has approved Diovan as a treatment for reducing cardiovascular deaths in patients who are at high risk after suffering a heart attack.
  The regulatory agency granted Novartis Pharmaceuticals Corp. the expanded heart failure labeling for the product, which the company says has been [...]]]></description>
			<content:encoded><![CDATA[<p>  EAST HANOVER, N.J. &#8212; The Food and Drug Administration has approved Diovan as a treatment for reducing cardiovascular deaths in patients who are at high risk after suffering a heart attack.<br />
  The regulatory agency granted Novartis Pharm<span id="more-46"></span>aceuticals Corp. the expanded heart failure labeling for the product, which the company says has been the world&#8217;s most prescribed ARB (angiotensin receptor blocker).<br />
  &#8220;Millions of patients already rely on Diovan to help them to maintain healthier blood pressure goals,&#8221; notes Alex Gorsky, chief operating officer. &#8220;Now, based on results from one of the largest mega-trial programs in the ARB class, Diovan has demonstrated additional benefits that can address the needs of an even broader spectrum of cardiovascular patients.</p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	</p>
<p>  &#8220;We remain committed to developing the full clinical potential of this agent.&#8221;<br />
  Each year an estimated 1.2 million Americans suffer a heart attack, which places them at expanded risk of repeat attacks or death. Patients who have experienced a heart attack may also progress to heart failure, a progressive condition in which the heart&#8217;s muscle weakens.<br />
  &#8220;Every day more than 3,000 patients suffer a heart attack in the United States,&#8221; points out Marc Pfeffer, professor of medicine at Harvard Medical School. &#8220;While we&#8217;ve made significant advances in recent years, death following a heart attack remains unacceptably high.&#8221;<br />
  The FDA&#8217;s approval of Diovan to reduce cardiovascular death in high-risk heart attack survivors is based on a landmark trial involving more than 14,000 patients in 24 countries.<br />
  &#8220;We are proud it has resulted in the approval of a new treatment to help improve the survival of patients at high risk following a heart attack,&#8221; adds Pfeffer, who also chaired the study that led to the FDA&#8217;s most recent approval.<br />
  Other recently completed Diovan trials involve patients with high blood pressure, while researchers continue to examine whether long-term treatment with the drug (which is also known as valsartan) delays or prevents the progression to type 2 diabetes.<br />
  For the treatment of heart failure, Diovan is available in 40-, 80- and 160-mg tablets (dosed twice daily). Diovan is also indicated for the first-line treatment of hypertension and can be administered once a day using a dosage range of 80 mg to 320 mg.<br />
COPYRIGHT 2005 Racher Press, Inc.<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/chain-drug-review-novartis-diovan-okd-for-a-new-use.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Chain Drug Review -  Drug combination</title>
		<link>http://www.orderdiovan.com/chain-drug-review-drug-combination.html</link>
		<comments>http://www.orderdiovan.com/chain-drug-review-drug-combination.html#comments</comments>
		<pubdate>Wed, 07 Jan 2009 08:36:05 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/chain-drug-review-drug-combination.html</guid>
		<description><![CDATA[  Novartis AG plans to combine its newer heart pill Tektuma with Diovan and says that it expects to bring the new therapy to market prior to the expiration of the patent for Diovan in 2012. Switzerland-based Novartis also indicates that Afinitor, a cancer therapy, may reach the market early next year. 
		Related Results
		DiovanDiovanDiovan [...]]]></description>
			<content:encoded><![CDATA[<p>  Novartis AG plans to combine its newer heart pill Tektuma with Diovan and says that it expects to bring the new therapy to market prior to the expiration of the patent for Diovan in 2012. Switzerland-based Novarti<span id="more-45"></span>s also indicates that Afinitor, a cancer therapy, may reach the market early next year. </p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	</p>
<p>The company also points out that an FDA panel recently reported that Coartem, its malaria medication, is safe and effective at treating the mosquito-borne illness. Coartem is already approved in over 80 countries.<br />
COPYRIGHT 2008 Racher Press, Inc.<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/chain-drug-review-drug-combination.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>MMR -  FDA approves Diovan</title>
		<link>http://www.orderdiovan.com/mmr-fda-approves-diovan.html</link>
		<comments>http://www.orderdiovan.com/mmr-fda-approves-diovan.html#comments</comments>
		<pubdate>Mon, 05 Jan 2009 21:06:07 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/mmr-fda-approves-diovan.html</guid>
		<description><![CDATA[  FDA APPROVES DIOVAN: Novartis Pharmaceuticals Corp. has announced that the Food and Drug Administration has approved Diovan (valsartan) for a new indication to reduce cardiovascular death in patients at high risk following a heart attack. As a result, the drug can now be prescribed in a broader range of heart-failure patients.
		Related Results
		DiovanDiovanDiovan dosesNew [...]]]></description>
			<content:encoded><![CDATA[<p>  FDA APPROVES DIOVAN: Novartis Pharmaceuticals Corp. has announced that the Food and Drug Administration has approved Diovan (valsartan) for a new indication to reduce cardiovascular death in patients at high risk following a heart attack. As a result, the drug can now be prescribed in a broader range of heart-failure patients.</p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesNew indication for diovanHill Holliday net<span id="more-44"></span>s Diovan	</p>
<p>COPYRIGHT 2005 Racher Press, Inc.<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/mmr-fda-approves-diovan.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Internal Medicine News -  Higher dose of Diovan HCT approved</title>
		<link>http://www.orderdiovan.com/internal-medicine-news-higher-dose-of-diovan-hct-approved.html</link>
		<comments>http://www.orderdiovan.com/internal-medicine-news-higher-dose-of-diovan-hct-approved.html#comments</comments>
		<pubdate>Thu, 01 Jan 2009 02:56:03 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/internal-medicine-news-higher-dose-of-diovan-hct-approved.html</guid>
		<description><![CDATA[  The FDA has approved the higher-dose formulations of Diovan HCT (valsartan/hydrochlorothiazide) for patients with high blood pressure. The medication is a combination of Diovan (valsartan), an angiotensin receptor blocker, and the diuretic hydrochlorothiazide, and is now available in 320-mg/12.5-mg and 320-mg/25-mg tablets. 
		Related Results
		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	
For more information, visit [...]]]></description>
			<content:encoded><![CDATA[<p>  The FDA has approved the higher-dose formulations of Diovan HCT (valsartan/hydrochlorothiazide) for patients with high blood pressure. The medication is a combination of Diovan (valsartan), an angiotensin receptor blocker, and the diuretic hydrochlorothiazide, and is now available in 320-mg/12.5-mg and 320-mg/25-mg tablets. </p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indicatio<span id="more-43"></span>n for diovan	</p>
<p>For more information, visit www.pharma.us.novartis.com and click on &#8220;Prescribing Information.&#8221;<br />
COPYRIGHT 2006 International Medical News Group<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/internal-medicine-news-higher-dose-of-diovan-hct-approved.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>M2 Presswire -  Novartis receives FDA approvable letter for Diovan (valsartan) for the treatment of heart failure in patients not on an ACE inhibitor.</title>
		<link>http://www.orderdiovan.com/m2-presswire-novartis-receives-fda-approvable-letter-for-diovan-valsartan-for-the-treatment-of-heart-failure-in-patients-not-on-an-ace-inhibitor.html</link>
		<comments>http://www.orderdiovan.com/m2-presswire-novartis-receives-fda-approvable-letter-for-diovan-valsartan-for-the-treatment-of-heart-failure-in-patients-not-on-an-ace-inhibitor.html#comments</comments>
		<pubdate>Sat, 27 Dec 2008 23:01:05 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/m2-presswire-novartis-receives-fda-approvable-letter-for-diovan-valsartan-for-the-treatment-of-heart-failure-in-patients-not-on-an-ace-inhibitor.html</guid>
		<description><![CDATA[   M2 PRESSWIRE-25 October 2001-NOVARTIS: Novartis receives FDA  approvable letter for Diovan (valsartan) for the treatment of heart  failure in  patients not on an ACE inhibitor (C)1994-2001 M2  COMMUNICATIONS LTD    RDATE:25102001    East Hanover, New Jersey / Basel, Switzerland &#8212; Novartis announced   [...]]]></description>
			<content:encoded><![CDATA[<p>   M2 PRESSWIRE-25 October 2001-NOVARTIS: Novartis receives FDA  approvable letter for Diovan (valsartan) for the treatment of heart  failure in  patients not on an ACE inhibitor (C)1994-2001 M2  COMMUNICATIONS LTD    RDATE:25102001    East Hanover, New Jersey / Basel, Switzerland &#8212; Novartis announced   today that it has received an &#8220;approvable&#8221; letter from the US  Food and  Drug Administration (FDA) for Diovan (valsa<span id="more-42"></span>rtan) for the  treatment of  heart failure in patients not on an ACE inhibitor. </p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	</p>
<p>Final  approval is contingent on further analysis of existing data or possibly  the  &#8230;</p>
<p>					Read the rest of this article with a Free Trial at HighBeam Research.</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/m2-presswire-novartis-receives-fda-approvable-letter-for-diovan-valsartan-for-the-treatment-of-heart-failure-in-patients-not-on-an-ace-inhibitor.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Drug Store News -  Novartis drug diovan nears FDA approval for hypertension</title>
		<link>http://www.orderdiovan.com/drug-store-news-novartis-drug-diovan-nears-fda-approval-for-hypertension.html</link>
		<comments>http://www.orderdiovan.com/drug-store-news-novartis-drug-diovan-nears-fda-approval-for-hypertension.html#comments</comments>
		<pubdate>Fri, 26 Dec 2008 09:01:04 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/drug-store-news-novartis-drug-diovan-nears-fda-approval-for-hypertension.html</guid>
		<description><![CDATA[  Novartis received an &#8220;approvable&#8221; letter from the FDA for Diovan (valsartan) for the treatment of heart failure in patients not taking ACE inhibitors. Final approval, according to Novartis, hangs on further analysis of existing data or the submission of additional data. Diovan is a highly selective angiotensin II receptor blocker already approved for [...]]]></description>
			<content:encoded><![CDATA[<p>  Novartis received an &#8220;approvable&#8221; letter from the FDA for Diovan (valsartan) for the treatment of heart failure in patients not taking ACE inhibitors. Final approval, according to Novartis, hangs on further analysis of existing data or the submission of additional data. Diovan is a highly selective angiotensin II receptor blocker already approved for<span id="more-41"></span> first-line treatment of hypertension in more than 80 countries, including the United States, and is one of the fastest-growing branded prescription antihypertensives.</p>
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	</p>
<p>  An estimated 3 million patients worldwide take Diovan for high blood pressure. Heart failure, or progressive weakening of the heart muscle, is the fastest-growing cardiovascular disease in the world and has reached epidemic proportions in industrialized nations. Twenty million people worldwide have heart failure, and the condition is the most common reason why patients aged 65 or older are hospitalized.<br />
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/drug-store-news-novartis-drug-diovan-nears-fda-approval-for-hypertension.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Chain Drug Review -  Exforge given FDA approval as treatment for hypertension</title>
		<link>http://www.orderdiovan.com/chain-drug-review-exforge-given-fda-approval-as-treatment-for-hypertension.html</link>
		<comments>http://www.orderdiovan.com/chain-drug-review-exforge-given-fda-approval-as-treatment-for-hypertension.html#comments</comments>
		<pubdate>Mon, 22 Dec 2008 14:26:06 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/chain-drug-review-exforge-given-fda-approval-as-treatment-for-hypertension.html</guid>
		<description><![CDATA[
		Related Results
		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	
>  Exforge has received regulatory approval as a treatment for patients with high blood pressure. Manufacturer Novartis AG notes that the product combines in one tablet the two most commonly prescribed hypertension medicines in their categories: Diovan and Norvasc. The new product is expected to be available [...]]]></description>
			<content:encoded><![CDATA[
<p>		Related Results</p>
<p>		DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan	</p>
<p>>  Exforge has received regulatory approval as a treatment for patients with high blood pressure. Manufacturer Novartis AG notes that the product combines in one tablet the two most commonly prescribed hypertension medicines in their categories: Diovan and Norvasc. The new product is expected to be available in the United States in late September pending expiration of p<span id="more-40"></span>atent protection for amlodipine besylate (Norvasc).<br />
COPYRIGHT 2007 Racher Press, Inc.<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/chain-drug-review-exforge-given-fda-approval-as-treatment-for-hypertension.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Heart Failure -causes, Symptoms and Treatments</title>
		<link>http://www.orderdiovan.com/heart-failure-causes-symptoms-and-treatments.html</link>
		<comments>http://www.orderdiovan.com/heart-failure-causes-symptoms-and-treatments.html#comments</comments>
		<pubdate>Wed, 17 Dec 2008 13:56:03 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/heart-failure-causes-symptoms-and-treatments.html</guid>
		<description><![CDATA[
Congestive heart failure (CHF), congestive cardiac failure (CCF) or just heart failure, is a condition that can result from any structural or functional cardiac disorder that impairs the ability of the heart to fill with blood or pump a sufficient amount of blood through the body. It is not to be confused with &#8220;cessation of [...]]]></description>
			<content:encoded><![CDATA[<p>
Congestive heart failure (CHF), congestive cardiac failure (CCF) or just heart failure, is a condition that can result from any structural or functional cardiac disorder that impairs the ability of the heart to fill with blood or pump a sufficient amount of blood through the body. It is not to be confused w<span id="more-39"></span>ith &#8220;cessation of heartbeat&#8221;, which is known as asystole, or with cardiac arrest, which is the cessation of normal cardiac function with subsequent hemodynamic collapse leading to death.[citation needed] Because not all patients have volume overload at the time of initial or subsequent evaluation, the term &#8220;heart failure&#8221; (ICD-9 428.9) is preferred over the older term &#8220;congestive heart failure&#8221;.</p>
<p>What causes heart failure?</p>
<p>Heart failure has many different causes. Sometimes the exact cause can&#8217;t be found. The most common causes of heart failure are listed below:</p>
<p>Coronary artery disease (narrowing of the blood vessels to the heart)<br />
Problems with the heart muscle itself (known as cardiomyopathy)<br />
High blood pressure (also known as hypertension)</p>
<p>Any disorder that directly affects the heart can lead to heart failure, as can some disorders that indirectly affect the heart. Some disorders cause heart failure quickly; others do so only after many years. Some disorders cause systolic dysfunction, others cause diastolic dysfunction, and some disorders, such as high blood pressure and some heart valve disorders, can cause both types of dysfunction.</p>
<p>Symptoms of Heart Failure</p>
<p>Many symptoms of heart failure result from the congestion that develops as fluid backs up into the lungs and leaks into the tissues. Other symptoms result from inadequate delivery of oxygen-rich blood to the body&#8217;s tissues. Since heart failure can progress rapidly, it is essential to consult a doctor immediately if any of the following symptoms are detected.</p>
<p>Heart failure on the left</p>
<p>Heart failure on the left side can also make you breathless. This can happen at any time but often happens when you are active or laying in bed. During the night you may feel the need to sit up in bed or even to get some fresh air.</p>
<p>Blood &#8220;backs up&#8221; in the pulmonary veins (the vessels that return blood from the lungs to the heart) because the heart can&#8217;t keep up with the supply. This causes fluid to leak into the lungs.</p>
<p>To make matters worse, any or several of these conditions may coexist along with congestive heart failure.</p>
<p>Heart Failure Treatment</p>
<p>If you have heart failure, your doctor will monitor you closely. This means having follow up appointments at least every 3 to 6 months, figuring out any underlying cause and treating it, and periodic testing of your heart function. For example, an ultrasound of your heart, called an echocardiogram, will be done once in awhile to give an estimate of how well your heart is pumping blood with each stroke or beat.</p>
<p>Lifestyle Changes</p>
<p>These modifications often improve or control some of the factors contributing to heart failure. For example, people with heart failure will see an improvement if they:</p>
<p>Modify daily activities and get enough rest to avoid stressing the heart</p>
<p>Eat a heart-healthy diet that is low in sodium and fat</p>
<p>Don&#8217;t smoke and avoid exposure to second-hand smoke</p>
<p>Angiotensin II (A-II) receptor blockers (ARBs). These drugs, which include losartan (Cozaar) and valsartan (Diovan), have many of the beneficial effects of ACE inhibitors, but they don&#8217;t cause a persistent cough. They may be an alternative for people who can&#8217;t tolerate ACE inhibitors.</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/heart-failure-causes-symptoms-and-treatments.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>Business Wire -  Pharmaceutical Pricing and Distribution in Japan Incorporates All Pricing Rule Changes That Came into Effect from April 2008</title>
		<link>http://www.orderdiovan.com/business-wire-pharmaceutical-pricing-and-distribution-in-japan-incorporates-all-pricing-rule-changes-that-came-into-effect-from-april-2008.html</link>
		<comments>http://www.orderdiovan.com/business-wire-pharmaceutical-pricing-and-distribution-in-japan-incorporates-all-pricing-rule-changes-that-came-into-effect-from-april-2008.html#comments</comments>
		<pubdate>Wed, 10 Dec 2008 20:51:03 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/business-wire-pharmaceutical-pricing-and-distribution-in-japan-incorporates-all-pricing-rule-changes-that-came-into-effect-from-april-2008.html</guid>
		<description><![CDATA[  DUBLIN, Ireland &#8212; Research and Markets (http://www.researchandmarkets.com/research/b2dd9e/pharmaceutical_pri) has announced the addition of the &#8220;Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world&#8217;s second largest market&#8221; report to their offering.
  No serious multinational can afford to ignore Japan, but it remains a tough and highly competitive market to crack, [...]]]></description>
			<content:encoded><![CDATA[<p>  DUBLIN, Ireland &#8212; Research and Markets (http://www.researchandmarkets.com/research/b2dd9e/pharmaceutical_pri) has announced the addition of the &#8220;Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world&#8217;s second largest market&#8221; report to their offering.<br />
  No serious multinational can afford to ignore Japan, but it remains a tough and highly competitive market to crack, with the environment for dev<span id="more-38"></span>eloping and marketing medicines dominated by price. Virtually no new prescription brand can be introduced without a yakka (reimbursement price) set by the government. Innovative new drugs receive price premiums while others are capped at the price of older entrants. Discounting to the trade is inescapable, but is punished by downward price revisions on a scale and frequency unseen elsewhere. Big selling brands and now others in the same class are subject to special price cuts. Distribution is inherently linked to the pricing process and is particularly opaque to outsiders.</p>
<p>   Most Popular<br />
   3 Questions No Job Seeker Ever Wants To Be Asked?<br />
   5 Regular Mistakes In Public Speaking<br />
   13 Job Interview Mistakes To Avoid<br />
   10 Jobs That Pay $30 An Hour<br />
   Public Speaking: 7 Secrets Of Great Public Speakers</p>
<p>  Whether the challenge is entering the Japanese market for the first time, moving up the all-important ranking there by market share, or negotiating with a local in-licensing partner, this report is designed to help.<br />
  - New drug pricing and price revision processes explained<br />
  - Written by an acknowledged expert on the Japanese market with 20 years&#8217; experience<br />
  - Fully researched through field interviews conducted in Tokyo and Osaka with industry leaders, government officials and others during March 2008<br />
  - Incorporates all pricing rule changes that came into effect from April 2008<br />
  - Pro-generic measures critically appraised<br />
  - Key role of wholesalers and how they are paid clarified<br />
  - Prospects for future reform to the P&#038;R processes discussed<br />
  Key Topics Covered:<br />
  1. Organisation &#038; Funding of Healthcare System<br />
  2. Regulatory Environment<br />
  3. Pharmaceutical Business Environment<br />
  4. Launch Price Setting<br />
  5. Price Revision Process<br />
  6. Other Cost Containment Methods<br />
  7. Other Market Segments<br />
  8. Distribution<br />
  9. Future Prospects<br />
  List of tables<br />
  List of figures<br />
  Companies Mentioned:<br />
  Astellas<br />
  AstraZeneca<br />
  Banyu<br />
  Bayer-Schering<br />
  Boehringer Ingelheim<br />
  BMS<br />
  Chugai<br />
  Daiichi-Sankyo<br />
  Dainippon Sumitomo<br />
  Eisai<br />
  GSK<br />
  Hisamitsu<br />
  Hospira<br />
  Janssen<br />
  Kyowa<br />
  Hakko Kirin<br />
  Meiji Seika<br />
  Mitsubishi-Tanabe<br />
  Mylan<br />
  Nichi-Iko<br />
  Novartis<br />
  Ono<br />
  Otsuka<br />
  Pfizer<br />
  Roche<br />
  Sanofi-Aventis<br />
  Sandoz<br />
  Sato<br />
  Sawai<br />
  Servier<br />
  Shionogi<br />
  SolvaySuntory<br />
  SSP<br />
  Taiho<br />
  Taisho<br />
  Taiyo Yakuhin<br />
  Takeda<br />
  Teva<br />
  Towa<br />
  Yakult Honsha<br />
  Yoshitomi<br />
  Zeria<br />
  Products covered<br />
  Abilify<br />
  Aldurazyme<br />
  Amlodin<br />
  Aricept<br />
  Avastin<br />
  Blopress<br />
  Campto<br />
  Clarith<br />
  Claritin<br />
  Coversyl<br />
  Crestor<br />
  Depromel<br />
  Diovan<br />
  Doral<br />
  Enbrel<br />
  Epogin<br />
  Evista<br />
  Exjade<br />
  Fabrazyme<br />
  Farom<br />
  Funguard<br />
  Gaster<br />
  Glivec<br />
  Harnal<br />
  Iressa<br />
  J-Zoloft<br />
  Lantus<br />
  Leuplin<br />
  Lipitor<br />
  Luvox<br />
  Maxalt<br />
  Mevalotin<br />
  Micardis<br />
  Mohrus Tape<br />
  Myozyme<br />
  Naglazyme<br />
  Nexavar<br />
  Nicotinell TTS<br />
  Norvasc<br />
  Nu-Lotan<br />
  Olmetec<br />
  Omepral<br />
  Pariet<br />
  Paxil<br />
  Pegasys<br />
  Preminent<br />
  Prograf<br />
  Radicut<br />
  Relenza<br />
  Remicade<br />
  Renivace<br />
  Revatio<br />
  Risperdal<br />
  Somavert<br />
  Sutent<br />
  Takepron<br />
  Taxol<br />
  Topotecin<br />
  Tracleer<br />
  Valtrex<br />
  Vesicare<br />
  Viagra<br />
  Zetia<br />
  Zoloft<br />
  Zovirax.<br />
  For more information visit http://www.researchandmarkets.com/research/b2dd9e/pharmaceutical_pri<br />
COPYRIGHT 2008 Business Wire<br />
COPYRIGHT 2008 Gale, Cengage Learning</p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/business-wire-pharmaceutical-pricing-and-distribution-in-japan-incorporates-all-pricing-rule-changes-that-came-into-effect-from-april-2008.html/feed</wfw:commentrss>
		</item>
		<item>
		<title>With Record Number of Uninsured, Consumers Turn to Foreign Pharmacies for Lowest-Price Prescription</title>
		<link>http://www.orderdiovan.com/with-record-number-of-uninsured-consumers-turn-to-foreign-pharmacies-for-lowest-price-prescription.html</link>
		<comments>http://www.orderdiovan.com/with-record-number-of-uninsured-consumers-turn-to-foreign-pharmacies-for-lowest-price-prescription.html#comments</comments>
		<pubdate>Fri, 05 Dec 2008 03:51:07 +0000</pubdate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid ispermalink="false">http://www.orderdiovan.com/with-record-number-of-uninsured-consumers-turn-to-foreign-pharmacies-for-lowest-price-prescription.html</guid>
		<description><![CDATA[FOR IMMEDIATE RELEASE
June 10, 2008
WITH RECORD NUMBER OF UNINSURED,
AMERICANS TURN TO FOREIGN PHARMACIES FOR
LOWEST-PRICE PRESCRIPTION DRUGS
Consumers Find Indian Pharmacies A Cheaper Resource Than
Canadian Pharmacies, and
Discount-Priced Generic Medications Are Available
TAMPA, Florida  With the number of uninsured Americans at a record 47 million, the highest number in more than 20 years*, a growing number of U.S. [...]]]></description>
			<content:encoded><![CDATA[<p>FOR IMMEDIATE RELEASE<br />
June 10, 2008</p>
<p>WITH RECORD NUMBER OF UNINSURED,<br />
AMERICANS TURN TO FOREIGN PHARMACIES FOR<br />
LOWEST-PRICE PRESCRIPTION DRUGS</p>
<p>Consumers Find Indian Pharmacies A Cheaper Resource Than<br />
Canadian Pharmacies, and<br />
Discount-Priced Generic Medications Are Available</p>
<p>TAMPA, Florida  With the number of uninsured Americans at a record 47 million, the highest number in more than 20 years*, a growing number of<span id="more-37"></span> U.S. consumers are buying their prescription drugs from foreign pharmacies, some as far as 8,000 miles away in India.  (* Source: US Census, Figure 6, page 27 of 78, http://www.census.gov/prod/2007pubs/p60-233.pdf )  There, they can access the highest quality brand-name and generic drugs at up to 90 percent savings off U.S. prices.<br />
	While a few years ago, many American consumers shopped at Canadian online pharmacies to find cheap drug prices, an increasing number of seniors especially have discovered India as a discount paradise for even lower-cost medications, taken by millions of consumers worldwide.<br />
	Cecilia, an uninsured senior in the Tampa, Florida suburb of Oldsmar, cant afford to buy her high blood pressure and arthritis drugs from her local pharmacy.  The same with Rex, a 72-year-old uninsured Houston veteran, who takes several medications to treat emphysema and COPD.  They both are buying their drugs from a licensed pharmacy in India.<br />
	American consumers are smart and know an amazing deal when they find it, said Pradeep Dadha, who runs InternationalDrugMart.com, a licensed pharmacy in Chennai, Indias fourth largest city and a major business center. This year our U.S. sales have climbed 25 percent over last year.  Every day, we fill and mail about 250 orders to our uninsured American patients, Dadha said.  Our U.S. customers are mainly 50 to 64-year olds that dont yet have Medicare coverage, and other uninsured people of all ages.  Most of our new business comes from word-of-mouth from our customers that recognize that they cannot find a better buy anywhere else, and they tell their friends and neighbors.<br />
	Their customers are pleased with the money-saving pharmacy.<br />
	International Drug Mart has been a godsend because we (seniors) cant afford U.S. drug companies high costs, said Rex.  </p>
<p>50 to 90 Percent Price Differences<br />
	Many medications in India cost 50 to 90 percent less than U.S. retail prices because the Indian government, like that of most countries worldwide,  controls drug pricing.  Also, Indian pharmacies can sell cheaper, generic versions of Lipitor, Diovan and other expensive brand-name drugs for which generic medications are typically unavailable at U.S. and Canadian pharmacies.  While generics can go to market quickly in India, the United States has strict U.S. drug patent protections that often prevent generics from coming to market for years.  This gives Indian pharmacies a distinct price advantage.<br />
	For example, the cholesterol lowering drug Lipitor (40mg/90tablets) costs $361.99 at CVS.com, a U.S. online pharmacy.  In comparison,   InternationalDrugMart.com sells a generic version of the identical drug for $127.31, a 65 percent savings. And, the high blood pressure medication Diovan (160mg/90tabs) costs $224.68 at Walmart.com, a U.S. discount pharmacy.  At InternationalDrugMart.com, Generic Diovan is $88.07, a 61 percent savings.  (All prices in US$ as of 6 June 2008 and subject to change)  Neither U.S. pharmacy sells generic versions of either drug.<br />
	Visitors to the Indian pharmacys website can obtain drug prices in less than 30 seconds time, and all prices are marked in U.S. dollars.<br />
	Dadhas staff of 10 people, includes two licensed pharmacists that manage orders for U.S. and other international customers and operates 24 hours a day, 7 days a week.  When a U.S. order arrives, his team follows a careful and stringent four-step safety process to complete it.  Finished orders are typically sent out one to two business days after receipt.   They also serve customers in other countries including the UK, France, Switzerland, Japan and Canada.<br />
	Our U.S. customers urgently need their discount-priced medications so we work very fast, said Dadha, who like many of his U.S. counterparts, counts on his Blackberry phone to sends quick text messages to business associates and suppliers during his 15-hour work days.<br />
	Dadha never would have dreamed that he would one day serve U.S. customers.<br />
	I couldnt imagine that there were customers that because of financial constraints would be on the brink of deciding whether they could afford their medications or their food, but not both &#8212; especially in the U.S.  It gives me considerable satisfaction to know that we can help American customers, and that they dont need to sacrifice one for the other, Dadha added.<br />
	As a testament to Indias low drug prices, Dadha says several Indian pharmacies fill orders for Canadian mail order pharmacies serving American customers.<br />
Customers Protect Their Health<br />
	Indian drugs are usually made there by world-class drug companies recognized for high quality including Wyeth, Pfizer, GlaxoSmithKline and Novartis.     And, leading Indian generic drug companies produce generic versions of many medications that they distribute for sale in India and worldwide.  These companies include Ranbaxy, CIPLA, Torrent Pharmaceuticals and Sun Pharma.<br />
	While the U.S. government says that it is usually illegal for Americans to buy drugs overseas that isnt preventing cost-conscious seniors from protecting their good health.  The U.S. Food and Drug Administration has been focused on finding rogue pharmacies, not on tracking down a fixed-income grandma who is buying cheaper drugs overseas for her personal use.<br />
	Ironically, many prescription drugs bought at U.S. pharmacies are made overseas.  According to the Newark Star-Ledger (May 2, 2008), An estimated four out of 10 prescription drugs sold in the United States are manufactured abroad, and about 80 percent of the active pharmaceutical ingredients used by U.S. manufacturers to make prescription drugs are imported.<br />
 The U.S. has the highest drug prices in the world and is one of few countries that does not control prices that drugmakers charge.  This puts the uninsured, or 15.8 percent of the population, (Source: US Census, same as graph #3), and many that cannot afford the steep costs, at greatest risk.<br />
	To reach InternationalDrugMart.com, visit its website at www.internationaldrugmart.com or call toll-free, 1-866-419-7475.  Pharmacy phone hours are 9:00 am to 8:00 pm Eastern time (6:00 am to 5:00 pm Pacific).  A prescription is required for prescription medications, and patients can order up to a three-month supply of drugs at one time.   Regular air mail delivery costs US$6.99 for any size order and takes about two to three weeks to arrive.   The pharmacy is approved by PharmacyChecker.com, a leading independent pharmacy verification program.    #  #  #</p>
<p>CONSUMER CONTACT: 1-866-419-7475</p>
<p>MEDIA CONTACT:<br />
To develop a story and interview Pradeep Dadha, Managing Director of InternationalDrugMart.com, or a local customer of the pharmacy, email Michael Pirages of Pirages Communications (Chicago) at mpirages@piragescom.com or call<br />
773-769-1616. Michael also can provide color jpg photos of the InternationalDrugMart.com pharmacy. </p>
]]></content:encoded>
			<wfw:commentrss>http://www.orderdiovan.com/with-record-number-of-uninsured-consumers-turn-to-foreign-pharmacies-for-lowest-price-prescription.html/feed</wfw:commentrss>
		</item>
	</channel>
</rss>
